IMP321 proven for breast & skin cancers treatments..

This is a positive proof saying IMP321 can be used to treat breast cancer and the largest Aussie killer skin cancer as well...

This is a good news.. why the market does not respond I wonder ???

Am I missing something here ????


TACTI-mel: (Two ACTive Immunotherapeutics in melanoma), the Company’s Australian melanoma trial has completed recruitment of the first two cohorts of six patients and has now commenced recruitment of the third cohort. No dose limiting toxicity has been observed in any patient. Patients with unresectable or metastatic melanoma will be dosed with IMP321 in combination with an approved checkpoint inhibitor (anti-PD-1 antibody) after the patient did not optimally respond to the checkpoint inhibitor alone.

As previously disclosed, data from the first cohort was presented in March at the ICI conference in Boston. This included one patient with complete remission after progress on anti-PD-1 therapy alone. This patient remains in complete remission, while other patients from the first cohort have shown a partial remission and stabilizations of disease...